Clinical Trial Update: Observational Study of Heart Valve Disease in Patients With Parkinson's Disease Treated With Pergolide

View source ↗

Summary

An observational study update examining the risk of heart valve disease in Parkinson's disease patients treated with pergolide.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Valvular Heart Disease

Drugs mentioned

• Permax (Pergolide mesylate) (Pergolide mesylate)

Snippet

Sponsor: Société Française de Cardiologie | Conditions: Parkinson's Disease, Pergolide | Status: COMPLETED